跳至主要内容
临床试验/CTRI/2020/05/025239
CTRI/2020/05/025239尚未招募1 期

A PHARMACO-CLINICAL STUDY FOR EVALUATION OF SHILAJATU FOR PREVENTIVE AND CURATIVE MANAGEMENT OF ASHMARI W.S.R. TO UROLITHIASIS - UroShil

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with features urolithiasis and evidence of stone in kidney/ureter/bladder (KUB) less than 15 mm in size

排除标准

  • Patients below 18 years and above 60 years, Patient having renal stone size >15mm or stone at lower calyx of kidney, Patients with severe complications such as hydroureteronephrosis, upper urinary tract infections, renal insufficiency, and are requiring immediate or urgent intervention, Patients suffering from serious systemic disorders such as Diabetes mellitus, Hypertension etc. or any history of hypersensitivity to any herbal formulation, Pregnant or lactating women

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验